JPY2,886.50
1.97% day before yesterday
Tokyo, Nov 01, 07:10 am CET
ISIN
JP3546800008
Symbol
4543
Index
Sector

Terumo Stock price

JPY2,886.50
+159.50 5.85% 1M
+227.50 8.56% 6M
+575.50 24.90% YTD
+797.00 38.14% 1Y
+330.00 12.91% 3Y
+1,114.00 62.85% 5Y
+2,203.50 322.62% 10Y
Tokyo, Closing price Fri, Nov 01 2024
-58.00 1.97%
ISIN
JP3546800008
Symbol
4543
Index
Sector

Key metrics

Market capitalization JPY4.29t
Enterprise Value JPY4.29t
P/E (TTM) P/E ratio 36.46
EV/FCF (TTM) EV/FCF 39.23
EV/Sales (TTM) EV/Sales 4.44
P/S ratio (TTM) P/S ratio 4.44
P/B ratio (TTM) P/B ratio 3.02
Dividend yield 0.90%
Last dividend (FY25) JPY26.00
Revenue growth (TTM) Revenue growth 15.12%
Revenue (TTM) Revenue JPY964.80b
EBIT (operating result TTM) EBIT JPY150.30b
Free Cash Flow (TTM) Free Cash Flow JPY109.26b
Cash position JPY194.91b
EPS (TTM) EPS JPY79.18
P/E forward 33.14
P/S forward 4.22
EV/Sales forward 4.22
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Terumo forecast:

12x Buy
75%
4x Hold
25%

Analyst Opinions

16 Analysts have issued a Terumo forecast:

Buy
75%
Hold
25%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
964,804 964,804
15% 15%
100%
- Direct Costs 457,858 457,858
11% 11%
47%
506,946 506,946
19% 19%
53%
- Selling and Administrative Expenses 276,853 276,853
58% 58%
29%
- Research and Development Expense - -
-
-
230,093 230,093
23% 23%
24%
- Depreciation and Amortization 79,789 79,789
11% 11%
8%
EBIT (Operating Income) EBIT 150,304 150,304
30% 30%
16%
Net Profit 117,715 117,715
32% 32%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 30,591
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today